Atara Biotherapeutics Director James Huang Disposes of $3.16 Million in Common Stock
James Huang, a director and ten percent owner of Atara Biotherapeutics, Inc. (NASDAQ: ATRA), has reported a substantial sale of company shares. Alongside Panacea Innovation Ltd., Huang executed the disposal of 313,446 shares of common stock on May 7, 2026. The total value realized from this transaction amounted to $3,165,020, based on a weighted av…